MALAT1 and thyroid gland carcinoma: A previous study reported that lncRNA MALAT1 (ENSG00000251562 of the TRLs signature) promotes tumor angiogenesis in thyroid cancer by regulating functions of macrophage in the TIME (Huang et al., 2017).